Analystreport

Theravance Biopharma Inc (NASDAQ: TBPH) was upgraded by analysts at Robert W. Baird from an "underperform" rating to a "neutral" rating. They now have a $18.00 price target on the stock, ...

Theravance Biopharma, Inc. - Ordinary Shares  (TBPH) 
Last theravance biopharma, inc. - ordinary shares earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.theravance.com/investor-relations